|
|
|
|
|
|
|
By Tom von Gunden, Chief Editor, Drug Delivery Leader
|
In this videocast, Chief Scientific Officer Ying Tam from Acuitas Therapeutics discusses the use of lipid nanoparticles as RNA delivery vehicles. Among the LNP advances are delivering CAR-T therapies in vivo and loading personalized therapeutic payloads into preformed vesicles.
|
|
|
|
|
|
Oral Combination Therapies: Navigating Development Complexities
|
|
A conversation with Joel Latham, Incannex Healthcare
|
The article's featured discussion focuses on how an oral delivery strategy influences development decisions. It includes learnings from advancing IHL-42X and points to the future of patient-centric drug delivery.
|
|
|
|
|
|
|
|
Scaling Safe, Consistent Drug Delivery in Modern Care
|
|
White Paper | Battelle
|
Assistive drug delivery technologies, including wearable injectors, smart infusion systems, and guided delivery tools, help standardize dosing, reduce variability, and expand access across care settings.
|
|
|
|
|
|
|
|
Success Factors For Pre-Filled Syringe CMO Selection
|
|
Article | By Jon Turkowski, Jon Best, and Juan. C. Sáez-Miranda, AbbVie
|
Within the past few decades, there has been a steady increase in the use of pre-filled syringes (PFS) for parenteral administration of biologics, biosimilars, and other drugs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
